Listed

Nephros Inc

NEPHNasdaqCIK 1196298HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$6.0m, Q2 FY2026
Operating income$1.2m, Q2 FY2026
Net income$1.2m, Q2 FY2026
Nephros Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k3,742Revenue, Q3 FY2023, three months to 2023-09-30$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure3,254Revenue, Q4 FY2023, three months to 2023-12-31$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0001641172-25-000234. Derived: 12-month figure less the 9-month figure.Report this figure3,522Revenue, Q1 FY2024, three months to 2024-03-31$3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure3,252Revenue, Q2 FY2024, three months to 2024-06-30$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure3,518Revenue, Q3 FY2024, three months to 2024-09-30$3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure3,870Revenue, Q4 FY2024, three months to 2024-12-31$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure4,877Revenue, Q1 FY2025, three months to 2025-03-31$4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure4,419Revenue, Q2 FY2025, three months to 2025-06-30$4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure4,764Revenue, Q3 FY2025, three months to 2025-09-30$4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure4,729Revenue, Q4 FY2025, three months to 2025-12-31$4.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure5,212Revenue, Q1 FY2026, three months to 2026-03-31$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure6,017Revenue, Q2 FY2026, three months to 2026-06-30$6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Cost of revenue$k1,548Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure1,233Cost of revenue, Q4 FY2023, three months to 2023-12-31$1.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-24, accession 0001641172-25-000234. Derived: 12-month figure less the 9-month figure.Report this figure1,335Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure1,340Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure1,369Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure1,395Cost of revenue, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure1,723Cost of revenue, Q1 FY2025, three months to 2025-03-31$1.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure1,624Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure1,849Cost of revenue, Q3 FY2025, three months to 2025-09-30$1.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure1,968Cost of revenue, Q4 FY2025, three months to 2025-12-31$2.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure2,219Cost of revenue, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure1,991Cost of revenue, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Gross profit$k2,194Gross profit, Q3 FY2023, three months to 2023-09-30$2.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure2,021Gross profit, Q4 FY2023, three months to 2023-12-31$2.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-24, accession 0001641172-25-000234. Derived: 12-month figure less the 9-month figure.Report this figure2,187Gross profit, Q1 FY2024, three months to 2024-03-31$2.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure1,912Gross profit, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure2,149Gross profit, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure2,475Gross profit, Q4 FY2024, three months to 2024-12-31$2.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure3,154Gross profit, Q1 FY2025, three months to 2025-03-31$3.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure2,795Gross profit, Q2 FY2025, three months to 2025-06-30$2.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure2,915Gross profit, Q3 FY2025, three months to 2025-09-30$2.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure2,761Gross profit, Q4 FY2025, three months to 2025-12-31$2.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure2,993Gross profit, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure4,026Gross profit, Q2 FY2026, three months to 2026-06-30$4.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Research and development$k205Research and development, Q3 FY2023, three months to 2023-09-30$205.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure208Research and development, Q4 FY2023, three months to 2023-12-31$208.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0001641172-25-000234. Derived: 12-month figure less the 9-month figure.Report this figure212Research and development, Q1 FY2024, three months to 2024-03-31$212.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure254Research and development, Q2 FY2024, three months to 2024-06-30$254.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure188Research and development, Q3 FY2024, three months to 2024-09-30$188.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure252Research and development, Q4 FY2024, three months to 2024-12-31$252.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure295Research and development, Q1 FY2025, three months to 2025-03-31$295.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure311Research and development, Q2 FY2025, three months to 2025-06-30$311.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure338Research and development, Q3 FY2025, three months to 2025-09-30$338.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure395Research and development, Q4 FY2025, three months to 2025-12-31$395.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure346Research and development, Q1 FY2026, three months to 2026-03-31$346.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure366Research and development, Q2 FY2026, three months to 2026-06-30$366.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Selling, general and administrative$k2,137Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure2,411Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-24, accession 0001641172-25-000234. Derived: 12-month figure less the 9-month figure.Report this figure2,142Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure1,941Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure1,721Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure1,872Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure2,254Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure2,201Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure2,229Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure2,316Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure2,521Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure2,418Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Operating income$k(203)Operating income, Q3 FY2023, three months to 2023-09-30−$203.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure(649)Operating income, Q4 FY2023, three months to 2023-12-31−$649.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0001641172-25-000234. Derived: 12-month figure less the 9-month figure.Report this figure(200)Operating income, Q1 FY2024, three months to 2024-03-31−$200.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure(317)Operating income, Q2 FY2024, three months to 2024-06-30−$317.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure206Operating income, Q3 FY2024, three months to 2024-09-30$206.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure317Operating income, Q4 FY2024, three months to 2024-12-31$317.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure566Operating income, Q1 FY2025, three months to 2025-03-31$566.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure248Operating income, Q2 FY2025, three months to 2025-06-30$248.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure314Operating income, Q3 FY2025, three months to 2025-09-30$314.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure18.0Operating income, Q4 FY2025, three months to 2025-12-31$18.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure97.0Operating income, Q1 FY2026, three months to 2026-03-31$97.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure1,213Operating income, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Interest expense$k0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-08, accession 0001493152-23-039890. Derived: 9-month figure less the 6-month figure.Report this figure1.0Interest expense, Q4 FY2023, three months to 2023-12-31$1.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-15, accession 0001493152-24-010107. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2024, three months to 2024-03-31$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001493152-24-018483.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0001641172-25-022596. Derived: 6-month figure less the 3-month figure.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001493152-25-021061. Derived: 9-month figure less the 6-month figure.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figurenot reported1.0Interest expense, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001493152-25-021061. Derived: 9-month figure less the 6-month figure.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figurenot reported1.0Interest expense, Q2 FY2026, three months to 2026-06-30$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Income tax$k0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-03-15, accession 0001493152-24-010107. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-09, accession 0001493152-24-018483.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-08, accession 0001493152-24-030745.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure15.0Income tax, Q4 FY2024, three months to 2024-12-31$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure9.0Income tax, Q2 FY2025, three months to 2025-06-30$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure3.0Income tax, Q3 FY2025, three months to 2025-09-30$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure13.0Income tax, Q2 FY2026, three months to 2026-06-30$13.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Net income$k(182)Net income, Q3 FY2023, three months to 2023-09-30−$182.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure(654)Net income, Q4 FY2023, three months to 2023-12-31−$654.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0001641172-25-000234. Derived: 12-month figure less the 9-month figure.Report this figure(169)Net income, Q1 FY2024, three months to 2024-03-31−$169.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure(289)Net income, Q2 FY2024, three months to 2024-06-30−$289.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure183Net income, Q3 FY2024, three months to 2024-09-30$183.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure349Net income, Q4 FY2024, three months to 2024-12-31$349.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure558Net income, Q1 FY2025, three months to 2025-03-31$558.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure237Net income, Q2 FY2025, three months to 2025-06-30$237.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure337Net income, Q3 FY2025, three months to 2025-09-30$337.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure62.0Net income, Q4 FY2025, three months to 2025-12-31$62.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure140Net income, Q1 FY2026, three months to 2026-03-31$140.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure1,197Net income, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Diluted EPS$ per share(0.02)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure(0.03)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure0.02Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figurenot reported0.05Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure0.02Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure0.03Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figurenot reported0.01Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure0.11Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Basic EPS$ per share(0.02)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figurenot reported(0.02)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure(0.03)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure0.02Basic EPS, Q3 FY2024, three months to 2024-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figurenot reported0.05Basic EPS, Q1 FY2025, three months to 2025-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure0.02Basic EPS, Q2 FY2025, three months to 2025-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure0.03Basic EPS, Q3 FY2025, three months to 2025-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figurenot reported0.01Basic EPS, Q1 FY2026, three months to 2026-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure0.11Basic EPS, Q2 FY2026, three months to 2026-06-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure

Balance sheet

Cash and equivalents$4.7m, Q2 FY2026
Shareholders' equity$12.0m, Q2 FY2026
Nephros Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m4.6Cash and equivalents, Q3 FY2023, at 2023-09-30$4.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001493152-23-039890.Report this figure4.3Cash and equivalents, FY2023, at 2023-12-31$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure3.6Cash and equivalents, Q1 FY2024, at 2024-03-31$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001493152-24-018483.Report this figure3.1Cash and equivalents, Q2 FY2024, at 2024-06-30$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001493152-24-030745.Report this figure2.5Cash and equivalents, Q3 FY2024, at 2024-09-30$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure3.8Cash and equivalents, FY2024, at 2024-12-31$3.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure4.1Cash and equivalents, Q1 FY2025, at 2025-03-31$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure5.1Cash and equivalents, Q2 FY2025, at 2025-06-30$5.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure5.2Cash and equivalents, Q3 FY2025, at 2025-09-30$5.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure5.4Cash and equivalents, FY2025, at 2025-12-31$5.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure4.0Cash and equivalents, Q1 FY2026, at 2026-03-31$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure4.7Cash and equivalents, Q2 FY2026, at 2026-06-30$4.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Current assets$m8.5Current assets, Q3 FY2023, at 2023-09-30$8.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001493152-23-039890.Report this figure8.4Current assets, FY2023, at 2023-12-31$8.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure8.1Current assets, Q1 FY2024, at 2024-03-31$8.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001493152-24-018483.Report this figure7.9Current assets, Q2 FY2024, at 2024-06-30$7.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030745.Report this figure7.4Current assets, Q3 FY2024, at 2024-09-30$7.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure8.3Current assets, FY2024, at 2024-12-31$8.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure9.0Current assets, Q1 FY2025, at 2025-03-31$9.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure9.6Current assets, Q2 FY2025, at 2025-06-30$9.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure10.7Current assets, Q3 FY2025, at 2025-09-30$10.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure11.2Current assets, FY2025, at 2025-12-31$11.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure11.5Current assets, Q1 FY2026, at 2026-03-31$11.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure13.6Current assets, Q2 FY2026, at 2026-06-30$13.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Total assets$m10.9Total assets, Q3 FY2023, at 2023-09-30$10.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001493152-23-039890.Report this figure11.9Total assets, FY2023, at 2023-12-31$11.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure11.4Total assets, Q1 FY2024, at 2024-03-31$11.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001493152-24-018483.Report this figure11.1Total assets, Q2 FY2024, at 2024-06-30$11.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001493152-24-030745.Report this figure10.4Total assets, Q3 FY2024, at 2024-09-30$10.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure11.2Total assets, FY2024, at 2024-12-31$11.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure11.8Total assets, Q1 FY2025, at 2025-03-31$11.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure12.2Total assets, Q2 FY2025, at 2025-06-30$12.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure13.2Total assets, Q3 FY2025, at 2025-09-30$13.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure13.6Total assets, FY2025, at 2025-12-31$13.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure13.8Total assets, Q1 FY2026, at 2026-03-31$13.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure15.8Total assets, Q2 FY2026, at 2026-06-30$15.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Current liabilities$m1.8Current liabilities, Q3 FY2023, at 2023-09-30$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001493152-23-039890.Report this figure2.1Current liabilities, FY2023, at 2023-12-31$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure1.9Current liabilities, Q1 FY2024, at 2024-03-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001493152-24-018483.Report this figure2.0Current liabilities, Q2 FY2024, at 2024-06-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030745.Report this figure1.1Current liabilities, Q3 FY2024, at 2024-09-30$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure1.6Current liabilities, FY2024, at 2024-12-31$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure1.5Current liabilities, Q1 FY2025, at 2025-03-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure1.8Current liabilities, Q2 FY2025, at 2025-06-30$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure2.5Current liabilities, Q3 FY2025, at 2025-09-30$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure2.8Current liabilities, FY2025, at 2025-12-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure2.5Current liabilities, Q1 FY2026, at 2026-03-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure3.3Current liabilities, Q2 FY2026, at 2026-06-30$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Total liabilities$m2.3Total liabilities, Q3 FY2023, at 2023-09-30$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001493152-23-039890.Report this figure3.5Total liabilities, FY2023, at 2023-12-31$3.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure3.2Total liabilities, Q1 FY2024, at 2024-03-31$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001493152-24-018483.Report this figure3.2Total liabilities, Q2 FY2024, at 2024-06-30$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001493152-24-030745.Report this figure2.2Total liabilities, Q3 FY2024, at 2024-09-30$2.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure2.6Total liabilities, FY2024, at 2024-12-31$2.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure2.5Total liabilities, Q1 FY2025, at 2025-03-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure2.6Total liabilities, Q2 FY2025, at 2025-06-30$2.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure3.2Total liabilities, Q3 FY2025, at 2025-09-30$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure3.4Total liabilities, FY2025, at 2025-12-31$3.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure3.1Total liabilities, Q1 FY2026, at 2026-03-31$3.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure3.8Total liabilities, Q2 FY2026, at 2026-06-30$3.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m8.6Shareholders' equity, Q3 FY2023, at 2023-09-30$8.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-08, accession 0001493152-23-039890.Report this figure8.4Shareholders' equity, FY2023, at 2023-12-31$8.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2024-03-15, accession 0001493152-24-010107.Report this figure8.2Shareholders' equity, Q1 FY2024, at 2024-03-31$8.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure7.9Shareholders' equity, Q2 FY2024, at 2024-06-30$7.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure8.2Shareholders' equity, Q3 FY2024, at 2024-09-30$8.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure8.6Shareholders' equity, FY2024, at 2024-12-31$8.6m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure9.3Shareholders' equity, Q1 FY2025, at 2025-03-31$9.3m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure9.6Shareholders' equity, Q2 FY2025, at 2025-06-30$9.6m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure10.0Shareholders' equity, Q3 FY2025, at 2025-09-30$10.0m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure10.2Shareholders' equity, FY2025, at 2025-12-31$10.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure10.7Shareholders' equity, Q1 FY2026, at 2026-03-31$10.7m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure12.0Shareholders' equity, Q2 FY2026, at 2026-06-30$12.0m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure

Cash flow

Operating cash flow$681.0k, Q2 FY2026
Capital expenditure$0, Q4 FY2024
Nephros Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k562Operating cash flow, Q3 FY2023, three months to 2023-09-30$562.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045793. Derived: 9-month figure less the 6-month figure.Report this figure(237)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$237.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0001641172-25-000234. Derived: 12-month figure less the 9-month figure.Report this figure(672)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$672.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure(501)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$501.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001641172-25-022596. Derived: 6-month figure less the 3-month figure.Report this figure(623)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$623.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001493152-25-021061. Derived: 9-month figure less the 6-month figure.Report this figure1,304Operating cash flow, Q4 FY2024, three months to 2024-12-31$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure322Operating cash flow, Q1 FY2025, three months to 2025-03-31$322.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure994Operating cash flow, Q2 FY2025, three months to 2025-06-30$994.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001493152-26-036851. Derived: 6-month figure less the 3-month figure.Report this figure99.0Operating cash flow, Q3 FY2025, three months to 2025-09-30$99.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001493152-25-021061. Derived: 9-month figure less the 6-month figure.Report this figure185Operating cash flow, Q4 FY2025, three months to 2025-12-31$185.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001493152-26-036851. Derived: 12-month figure less the 9-month figure.Report this figure(1,671)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure681Operating cash flow, Q2 FY2026, three months to 2026-06-30$681.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001493152-26-036851. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$knot reportednot reportednot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001493152-25-021061. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)11.11m, Q2 FY2026
Nephros Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares10.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3010,303,818 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001493152-23-039890.Report this figure10.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3110,297,429 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001493152-24-018483.Report this figure10.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3010,297,429 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001493152-24-030745.Report this figure10.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3010,460,866 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001493152-24-045793.Report this figure10.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3110,501,771 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001641172-25-010836.Report this figure10.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3010,509,937 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001641172-25-022596.Report this figure10.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3010,580,906 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure10.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3110,615,766 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure10.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3010,813,028 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure11.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3011,040,925 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure11.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3110,990,904 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure11.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3011,112,671 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure

Shares outstanding: 10.86mShares outstanding, period not labelled, at 2026-08-0710,860,120 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.